Skip to main content

Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry.

Publication ,  Journal Article
Stolker, JM; Kennedy, KF; Lindsey, JB; Marso, SP; Pencina, MJ; Cutlip, DE; Mauri, L; Kleiman, NS; Cohen, DJ; EVENT Investigators,
Published in: Circ Cardiovasc Interv
August 2010

BACKGROUND: Prediction of restenosis after percutaneous coronary intervention (PCI) remains challenging, and existing risk assessment algorithms were developed before the widespread adoption of drug-eluting stents (DES). METHODS AND RESULTS: We used data from the EVENT registry to develop a risk model for predicting target lesion revascularization (TLR) in 8829 unselected patients undergoing DES implantation between 2004 and 2007. Using a split-sample validation technique, predictors of TLR at 1 year were identified from two thirds of the subjects (derivation cohort) using multiple logistic regression. Integer point values were created for each predictor, and the summed risk score (range, 0 to 10) was applied to the remaining sample (validation cohort). At 1 year, TLR occurred in 4.2% of patients, and after excluding stent thrombosis and early mechanical complications, the incidence of late TLR (more likely representing restenosis-related TLR) was 3.6%. Predictors of TLR were age <60, prior PCI, unprotected left main PCI, saphenous vein graft PCI, minimum stent diameter < or =2.5 mm, and total stent length > or =40 mm. Comparison of observed versus predicted rates of TLR according to risk score demonstrated good model fit in the validation set. There was more than a 3-fold difference in TLR rates between the lowest risk category (score=0; TLR rate, 2.2%) and the highest risk category (score > or =5; TLR rate, 7.5%). CONCLUSIONS: The overall incidence of TLR remains low among unselected patients receiving DES in routine clinical practice. A simple risk model incorporating 6 readily available clinical and angiographic variables helps identify individuals at extremely low (<2%) and modestly increased (>7%) risk of TLR after DES implantation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

August 2010

Volume

3

Issue

4

Start / End Page

327 / 334

Location

United States

Related Subject Headings

  • Software Validation
  • Risk Assessment
  • Prognosis
  • Postoperative Complications
  • Male
  • Humans
  • Follow-Up Studies
  • Female
  • Drug-Eluting Stents
  • Coronary Restenosis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stolker, J. M., Kennedy, K. F., Lindsey, J. B., Marso, S. P., Pencina, M. J., Cutlip, D. E., … EVENT Investigators, . (2010). Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv, 3(4), 327–334. https://doi.org/10.1161/CIRCINTERVENTIONS.110.946939
Stolker, Joshua M., Kevin F. Kennedy, Jason B. Lindsey, Steven P. Marso, Michael J. Pencina, Donald E. Cutlip, Laura Mauri, Neal S. Kleiman, David J. Cohen, and David J. EVENT Investigators. “Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry.Circ Cardiovasc Interv 3, no. 4 (August 2010): 327–34. https://doi.org/10.1161/CIRCINTERVENTIONS.110.946939.
Stolker JM, Kennedy KF, Lindsey JB, Marso SP, Pencina MJ, Cutlip DE, et al. Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv. 2010 Aug;3(4):327–34.
Stolker, Joshua M., et al. “Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry.Circ Cardiovasc Interv, vol. 3, no. 4, Aug. 2010, pp. 327–34. Pubmed, doi:10.1161/CIRCINTERVENTIONS.110.946939.
Stolker JM, Kennedy KF, Lindsey JB, Marso SP, Pencina MJ, Cutlip DE, Mauri L, Kleiman NS, Cohen DJ, EVENT Investigators. Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv. 2010 Aug;3(4):327–334.

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

August 2010

Volume

3

Issue

4

Start / End Page

327 / 334

Location

United States

Related Subject Headings

  • Software Validation
  • Risk Assessment
  • Prognosis
  • Postoperative Complications
  • Male
  • Humans
  • Follow-Up Studies
  • Female
  • Drug-Eluting Stents
  • Coronary Restenosis